Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Cosgrove

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Medicine|February 7, 2024
Industry influence on mental health research: depression as a case exampleLisa Cosgrove, Elissa H Patterson, Harold J Bursztajn
Health and Human Rights|January 4, 2021
Digital Phenotyping and Digital Psychotropic Drugs: Mental Health Surveillance Tools That Threaten Human RightsLisa Cosgrove, Justin M Karter, Mallaigh McGinley, et al.
Accountability in Research|February 19, 2016
Under the Influence: The Interplay among Industry, Publishing, and Drug RegulationLisa Cosgrove, Steven Vannoy, Barbara Mintzes, et al.
International Journal of Law and Psychiatry|November 22, 2017
Antipsychotic augmentation for major depressive disorder: A review of clinical practice guidelinesPeter Simons, Lisa Cosgrove, Allen F Shaughnessy, et al.
BMJ Evidence-Based Medicine|June 29, 2018
Variation in analytic transparency in recent efficacy studies of antidepressant medicationSteven Vannoy, Madeline Brodt, Lisa Cosgrove, et al.
Translational Behavioral Medicine|October 16, 2018
Evidence-based practice: a comparison of International Clinical Practice Guidelines and current research on physical activity for mild to moderate depressionCourtney Wynne Hess, Justin Karter, Lisa Cosgrove, et al.
The Lancet. Psychiatry|November 20, 2022
New treatments for mental disorders should be routinely compared to psychotherapy in trials conducted for regulatory purposesIoana A Cristea, Joar Øveraas Halvorsen, Lisa Cosgrove, et al.
The Journal of Clinical Psychiatry|August 3, 2022
A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital AripiprazoleFlorian Naudet, André Gillibert, Barbara Mintzes, et al.
Journal of the American Board of Family Medicine : JABFM|August 25, 2025
"Medicine Is Awesome": A Critical Look at the Factors That Shape Thinking About Depression and Its TreatmentAllen F Shaughnessy, Joshua Passarelli, Sophie Pollack-Milgate, et al.
Journal of Psychosomatic Research|May 19, 2018
Unexamined assumptions and unintended consequences of routine screening for depressionLisa Cosgrove, Justin M Karter, Akansha Vaswani, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Medicine|February 7, 2024
Industry influence on mental health research: depression as a case exampleLisa Cosgrove, Elissa H Patterson, Harold J Bursztajn
Health and Human Rights|January 4, 2021
Digital Phenotyping and Digital Psychotropic Drugs: Mental Health Surveillance Tools That Threaten Human RightsLisa Cosgrove, Justin M Karter, Mallaigh McGinley, et al.
Accountability in Research|February 19, 2016
Under the Influence: The Interplay among Industry, Publishing, and Drug RegulationLisa Cosgrove, Steven Vannoy, Barbara Mintzes, et al.
International Journal of Law and Psychiatry|November 22, 2017
Antipsychotic augmentation for major depressive disorder: A review of clinical practice guidelinesPeter Simons, Lisa Cosgrove, Allen F Shaughnessy, et al.
BMJ Evidence-Based Medicine|June 29, 2018
Variation in analytic transparency in recent efficacy studies of antidepressant medicationSteven Vannoy, Madeline Brodt, Lisa Cosgrove, et al.
Translational Behavioral Medicine|October 16, 2018
Evidence-based practice: a comparison of International Clinical Practice Guidelines and current research on physical activity for mild to moderate depressionCourtney Wynne Hess, Justin Karter, Lisa Cosgrove, et al.
The Lancet. Psychiatry|November 20, 2022
New treatments for mental disorders should be routinely compared to psychotherapy in trials conducted for regulatory purposesIoana A Cristea, Joar Øveraas Halvorsen, Lisa Cosgrove, et al.
The Journal of Clinical Psychiatry|August 3, 2022
A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital AripiprazoleFlorian Naudet, André Gillibert, Barbara Mintzes, et al.
Journal of the American Board of Family Medicine : JABFM|August 25, 2025
"Medicine Is Awesome": A Critical Look at the Factors That Shape Thinking About Depression and Its TreatmentAllen F Shaughnessy, Joshua Passarelli, Sophie Pollack-Milgate, et al.
Journal of Psychosomatic Research|May 19, 2018
Unexamined assumptions and unintended consequences of routine screening for depressionLisa Cosgrove, Justin M Karter, Akansha Vaswani, et al.
Pageof 7